ZURICH — Switzerland plans to donate or sell approximately 4.5 million excess doses of the H1N1 flu vaccine because of the low uptake of shots, the government said, according to a Reuters report Dec. 18.
Germany and Spain have also said they want to reduce deliveries of H1N1 flu vaccine and potentially return excess supplies to manufacturers, which could hit drugmakers' profits.
"As not every person needs two doses, about 4.5 million of the purchased vaccine doses will be given up. Some of these would be donated to the WHO [World Health Organization] and others sold on to other countries," the Swiss government said in a statement.
The country would still have enough doses to protect the population in the event of a fresh wave of the H1N1 flu pandemic, it added.
Switzerland, whose total population is 7.7 million, ordered 13 million doses of vaccine from GlaxoSmithKline and Novartis.